Telos Capital Management, Inc. Moderna, Inc. Transaction History

Telos Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$135.66 - $197.02 $31,880 - $46,299	-235 Reduced 14.79%	1,354 $207,000
Q4 2022 Jan 27, 2023	BUY	$118.38 - $210.04 $188,105 - $333,753	1,589 New	1,589 $0
Q1 2022 May 02, 2022	SELL	$126.46 - $235.05 $126,586 - $235,285	-1,001 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$225.82 - $368.51 $44,034 - $71,859	-195 Reduced 16.3%	1,001 $254,000
Q3 2021 Oct 19, 2021	BUY	$221.9 - $484.47 $39,276 - $85,751	177 Added 17.37%	1,196 $460,000
Q2 2021 Jul 15, 2021	BUY	$129.91 - $234.98 $132,378 - $239,444	1,019 New	1,019 $239,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Telos Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Telos Capital Management, Inc. with notifications on news.